The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
- PMID:12032344
- PMCID: PMC124322
- DOI: 10.1073/pnas.122108599
The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is a major cause of hospital-acquired infections that are becoming increasingly difficult to combat because of emerging resistance to all current antibiotic classes. The evolutionary origins of MRSA are poorly understood, no rational nomenclature exists, and there is no consensus on the number of major MRSA clones or the relatedness of clones described from different countries. We resolve all of these issues and provide a more thorough and precise analysis of the evolution of MRSA clones than has previously been possible. Using multilocus sequence typing and an algorithm, BURST, we analyzed an international collection of 912 MRSA and methicillin-susceptible S. aureus (MSSA) isolates. We identified 11 major MRSA clones within five groups of related genotypes. The putative ancestral genotype of each group and the most parsimonious patterns of descent of isolates from each ancestor were inferred by using BURST, which, together with analysis of the methicillin resistance genes, established the likely evolutionary origins of each major MRSA clone, the genotype of the original MRSA clone and its MSSA progenitor, and the extent of acquisition and horizontal movement of the methicillin resistance genes. Major MRSA clones have arisen repeatedly from successful epidemic MSSA strains, and isolates with decreased susceptibility to vancomycin, the antibiotic of last resort, are arising from some of these major MRSA clones, highlighting a depressing progression of increasing drug resistance within a small number of ecologically successful S. aureus genotypes.
Figures




Similar articles
- The evolution of methicillin resistance in Staphylococcus aureus: similarity of genetic backgrounds in historically early methicillin-susceptible and -resistant isolates and contemporary epidemic clones.Crisóstomo MI, Westh H, Tomasz A, Chung M, Oliveira DC, de Lencastre H.Crisóstomo MI, et al.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9865-70. doi: 10.1073/pnas.161272898. Epub 2001 Jul 31.Proc Natl Acad Sci U S A. 2001.PMID:11481426Free PMC article.
- Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus.Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG.Enright MC, et al.J Clin Microbiol. 2000 Mar;38(3):1008-15. doi: 10.1128/JCM.38.3.1008-1015.2000.J Clin Microbiol. 2000.PMID:10698988Free PMC article.
- Evolution and molecular characterization of methicillin-resistant Staphylococcus aureus epidemic and sporadic clones in Cordoba, Argentina.Sola C, Cortes P, Saka HA, Vindel A, Bocco JL.Sola C, et al.J Clin Microbiol. 2006 Jan;44(1):192-200. doi: 10.1128/JCM.44.1.192-200.2006.J Clin Microbiol. 2006.PMID:16390969Free PMC article.
- Bridges from hospitals to the laboratory: genetic portraits of methicillin-resistant Staphylococcus aureus clones.Aires de Sousa M, de Lencastre H.Aires de Sousa M, et al.FEMS Immunol Med Microbiol. 2004 Mar 8;40(2):101-11. doi: 10.1016/S0928-8244(03)00370-5.FEMS Immunol Med Microbiol. 2004.PMID:15040388Review.
- Multilocus sequence typing and the evolution of methicillin-resistant Staphylococcus aureus.Robinson DA, Enright MC.Robinson DA, et al.Clin Microbiol Infect. 2004 Feb;10(2):92-7. doi: 10.1111/j.1469-0691.2004.00768.x.Clin Microbiol Infect. 2004.PMID:14759234Review.
Cited by
- Correlation Between Biofilm-Formation and the Antibiotic Resistant Phenotype inStaphylococcus aureus Isolates: A Laboratory-Based Study in Hungary and a Review of the Literature.Senobar Tahaei SA, Stájer A, Barrak I, Ostorházi E, Szabó D, Gajdács M.Senobar Tahaei SA, et al.Infect Drug Resist. 2021 Mar 23;14:1155-1168. doi: 10.2147/IDR.S303992. eCollection 2021.Infect Drug Resist. 2021.PMID:33790586Free PMC article.
- A combination of silver nanoparticles and visible blue light enhances the antibacterial efficacy of ineffective antibiotics against methicillin-resistant Staphylococcus aureus (MRSA).Akram FE, El-Tayeb T, Abou-Aisha K, El-Azizi M.Akram FE, et al.Ann Clin Microbiol Antimicrob. 2016 Aug 17;15(1):48. doi: 10.1186/s12941-016-0164-y.Ann Clin Microbiol Antimicrob. 2016.PMID:27530257Free PMC article.
- The survival of epidemic and sporadic MRSA on human skin mimics is determined by both host and bacterial factors.Baede VO, Voet MM, van der Reijden TJK, van Wengen A, Horst-Kreft DE, Lemmens-den Toom NA, Tavakol M, Vos MC, Nibbering PH, van Wamel WJB.Baede VO, et al.Epidemiol Infect. 2022 Nov 16;150:e203. doi: 10.1017/S0950268822001765.Epidemiol Infect. 2022.PMID:36382385Free PMC article.
- Use of Metagenomics and Isolation of Actinobacteria in Brazil's Atlantic Rainforest Soil for Antimicrobial Prospecting.Assis DA, Rezende RP, Dias JC.Assis DA, et al.ISRN Biotechnol. 2014 Mar 12;2014:909601. doi: 10.1155/2014/909601. eCollection 2014.ISRN Biotechnol. 2014.PMID:25937991Free PMC article.
- Characteristics of antibiotic resistance of airborne Staphylococcus isolated from metro stations.Zhou F, Wang Y.Zhou F, et al.Int J Environ Res Public Health. 2013 Jun 13;10(6):2412-26. doi: 10.3390/ijerph10062412.Int J Environ Res Public Health. 2013.PMID:23765189Free PMC article.
References
- Jevons M P. Br Med J. 1961;1:124–125.
- Hussain F M, Boyle-Vavra S, Bethel C D, Daum R S. Pediatr Infect Dis J. 2000;19:1163–1166. - PubMed
- Centers for Disease Control and Prevention. Morbid Mortal Wkly Rep. 1999;48:707–710. - PubMed
- Hiramatsu K, Cui L, Kuroda M, Ito T. Trends Microbiol. 2001;9:486–493. - PubMed
- Hiramatsu K, Kuroda M, Baba T, Okuma K. In: Diagnostic Molecular Microbiology. Persing D, editor. Washington, DC: Am. Soc. Microbiol.; 2002. , in press.
Publication types
MeSH terms
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources